POU2F2

Across TCGA pan-cancer cohorts, POU2F2 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated POU2F2 data layer compared with 20 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher POU2F2 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated POU2F2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

LUAD, HNSC, and GBM are the cancer types where POU2F2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.775	0.486	.012	13	view →
HNSC	DFS	Median	All	1.000	0.502	.049	8	view →
GBM	OS	Tertile	All	0.371	0.614	.034	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

POU2F2–LUAD (DFS)

Open the LUAD breakdown →